CLDX Celldex Therapeutics, Inc.
CLDX Celldex Therapeutics, Inc.
Healthcare · Biotechnology
Desk view
Market read
POC $31.22 · VWAP $31.63 · -13.0% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
CLDX Price Structure
Loading timeframes…
Peers
Every watchlist CLDX belongs to, members best 30-day change first — CLDX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How CLDX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about CLDX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 1 day ago · Oct 16
- CLDX Posts Celldex Therapeutics
- CLDX - Celldex Therapeutics Inc. stock news, filings & ratings | Quantisnow
- CLDX Stock Price, Quote & Chart | ChartMill.com
- Investors - Celldex Therapeutics
- CLDX Q2 2026 Earnings Report on 8/6/2026 - MarketBeat
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
CLDX research tape
42 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.